Findings similar to ours were reported in a recent population-based study, the BCblood cohort [24], where CAV1 was assessed in samples from 1018 patients with non-metastatic invasive BC, followed up for a median duration of 9.0 years, revealing that +cCAV1 was weakly linked to a higher risk of recurrence. The gene discussed is CAV1; the disease is breast cancer.